EC Number |
Inhibitors |
Structure |
---|
3.4.13.18 | (1S)-1-cyclohexyl-2-(1,3-dihydro-2H-isoindol-2-yl)-2-oxoethanamine |
IC50: 24 nM |
|
3.4.13.18 | (1S)-1-cyclohexyl-2-(3,4-dihydroisoquinolin-2(1H)-yl)-2-oxoethanamine |
IC50: 3016 nM |
|
3.4.13.18 | (1S)-1-cyclohexyl-2-oxo-2-piperidin-1-ylethanamine |
IC50: 1448 nM |
|
3.4.13.18 | (1S)-1-cyclohexyl-2-oxo-2-pyrrolidin-1-ylethanamine |
IC50: 78 nM |
|
3.4.13.18 | (2S)-1-[(2S)-2-amino-4-(3,4-dihydroisoquinolin-2(1H)-yl)-4-oxobutanoyl]pyrrolidine-2-carbonitrile |
IC50: 19 nM |
|
3.4.13.18 | (2S)-1-[(2S)-2-amino-4-(4-[bis(4-fluorophenyl)methyl]piperazin-1-yl)-4-oxobutanoyl]pyrrolidine-2-carbonitrile |
IC50: 16 nM |
|
3.4.13.18 | (2S)-2-amino-2-cyclohexyl-1-[(2R)-2-(iminomethyl)cyclopentyl]ethanone |
IC50: 27 nM |
|
3.4.13.18 | (2S,3S)-3-methyl-1-oxo-1-(1,3-thiazolidin-3-yl)pentan-2-amine |
IC50: 364 nM |
|
3.4.13.18 | 1,10-phenanthroline |
- |
|
3.4.13.18 | 1,10-phenanthroline |
1,7-phenanthroline has no effect |
|